Submit a speaking proposal
Dear Colleague:
Over the past seven years of organizing the HCA meeting, we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Eighth Annual High-Content Analysis 2011 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, and novel biological models for screening. We will also cover case studies and applications in compound screening, cytotoxicity evaluation, functional analysis, and more…
HCA 2011 will once again feature a variety of events designed to promote structured networking and brainstorming, as well as a comprehensive tradeshow, co-located user group meetings, technology showcases, and more.
Whether you are an HCA expert or a new adopter, this is the annual event you can't afford to miss!
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
HCA 2011 Key Features:
The most comprehensive coverage of high-content analysis applications and technologies:
Scientific Program features cutting-edge technology and applications presentations from pharma, academia, technology providers and more…
Unparalleled Networking with the largest gathering of HCA end-users and technology providers at an annual dedicated meeting (350+ delegates in 2010)
Comprehensive Trade Show offers a one-stop-shop for instrumentation, reagents, and informatics
Advanced HCA Course offers a perfect format to learn from the experts
User Group Meetings hosted by leading technology providers
ThinkTank Sessions allow to brainstorm key topics with fellow delegates in an informal setting
New Technology Showcase includes short talks from leading technology providers
Posters increase the scientific content
Topics Include:
HCA for Compound Screening and in vitro Toxicology
HCA for Pathway Analysis and Target Validation
Neuronal Screening
Novel Fluorescent Probes and Biosensors
Image Analysis and Data Management
Novel Applications for HCA Technology
Fluorescence Assays (FLIM, FRET, etc.)
New Biological Models for HCA
Live-Cell Imaging
Label-Free Screening
If you are interested in presenting, please submit a speaking proposal for review.
For more details on the conference, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
E: juliab@healthtech.com
For partnering and sponsorship information, please contact:
Katelin Fitzgerald
Manager, Business Development
T: 781-972-5458
E: kfitzgerald@healthtech.com